Lord’s Mark Industries Investor Meet Presentation Highlights
Lords Mark Industries Ltd · Investor Presentation · 15 Sept 2026, 11:50 pm
Lord’s Mark Industries Investor Meet Presentation Highlights Lord’s Mark Industries targets rapid growth driven by its IVD/MedTech, Renalyx dialysis, and solar verticals, forecasting revenue to surge from ₹710 Cr in FY25 to ₹2,638 Cr in FY29 (~25.2% CAGR) with EBITDA margins expanding to 15.1%. The company holds a ₹2,000 Cr secured clean energy order book within a ₹3,000+ Cr pipeline. Key strategic catalysts include a ₹500 Cr FPO/preferential allotment and NSE listing in FY27, an IVD/MedTech demerger by FY28, and a targeted $3 billion group valuation by 2029.
Original exchange filing (PDF)
More announcements from Lords Mark Industries Ltd
- Investor Presentation H1 · 18 Nov 2026
- Investor Meet on 19th Nov 2026 · 16 Nov 2026
- Revised Outcome of BM held on 14 Nov 2026 · 15 Nov 2026
- Revised financials for September 2026 · 15 Nov 2026
- Outcome of Board Meeting held on 14.11.2026 · 14 Nov 2026
- September 2026 results · 14 Nov 2026
- Lords Mark Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Board Meeting intimation .... · 14 Nov 2026
- Dr. Sachidanand Upadhyay , MD has featured in TIME magazine for third consecutive years . · 03 Nov 2026
